行情

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ

实时行情|Nasdaq Last Sale

4.300
-0.030
-0.69%
休市 16:00 09/20 EDT
开盘
4.390
昨收
4.330
最高
4.439
最低
4.260
成交量
5.26万
成交额
--
52周最高
6.86
52周最低
3.250
市值
8,689.12万
市盈率(TTM)
-5.5591
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ANIX 新闻

  • 日美贸易协定冲击波:部分日本农民或“失业”
  • 中国经营报.5小时前
  • 法媒:沙特石油设施遭袭凸显石油行业脆弱性
  • 参考消息.8小时前
  • 亚马逊曾拟1500万美元收购奈飞 现在奈飞市值超千亿
  • 新浪美股.8小时前
  • 沙特称伊朗应为石油设施遇袭负责 伊方驳斥:毫无根据
  • 央视.9小时前

更多

所属板块

生物技术和医学研究
+0.62%
制药与医学研究
+0.95%

热门股票

名称
价格
涨跌幅

ANIX 简况

Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek liquid biopsy technology is a series of non-invasive blood tests for early detection of solid tumors based on the body's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. This technology enables cancer detection in its earliest stages in efforts to treat patients when the disease is curable. The Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients.
展开

Webull提供Anixa Biosciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。